Publication | Open Access

Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

InflammationAnti-inflammatoryImmunologyGastroenterologyUlcerative ColitisSerum ConcentrationsMedicineReactive MonitoringLong-term OutcomesRheumatoid Arthritis